Information webinar for Swedish Life Sciences companies with the objective of developing an appetite for investment in the United Kingdom. The webinar will take into account the impact of the Covid-19 pandemic as well as questions around changes in regulations after the end of the EU-exit transition period.
The event will include presentations and a Q&A session.
Focus areas will be:
– The UK offer in clinical research;
– The UK offer in medtech;
– Accessing the NHS market and its procurement channels;
– Investor benefits.
UK Life Sciences Investment Opportunities, DIT Sweden webinar Nov. 3 (Flyer)
